Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
20 results:

  • 1. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
    Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
    Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon cancer-May Cold Tumors Simply Be Too Hot?
    Køstner AH; Nielsen PS; Georgsen JB; Parner ET; Nielsen MB; Kersten C; Steiniche T
    Front Immunol; 2021; 12():716342. PubMed ID: 34531864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon cancer via Inhibiting Immune Tolerance.
    Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the clinical outcome in colorectal cancer.
    Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
    Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.
    McCoy MJ; Hemmings C; Anyaegbu CC; Austin SJ; Lee-Pullen TF; Miller TJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
    Oncotarget; 2017 Mar; 8(12):19803-19813. PubMed ID: 28177891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA let-7, T Cells, and Patient Survival in colorectal cancer.
    Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low stromal foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.
    McCoy MJ; Hemmings C; Miller TJ; Austin SJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
    Br J Cancer; 2015 Dec; 113(12):1677-86. PubMed ID: 26645238
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Novel Immune Marker Model Predicts Oncological outcomes of Patients with colorectal cancer.
    Chen Y; Yuan R; Wu X; He X; Zeng Y; Fan X; Wang L; Wang J; Lan P; Wu X
    Ann Surg Oncol; 2016 Mar; 23(3):826-32. PubMed ID: 26581202
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced colorectal cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
    Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
    Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High intratumoral foxp3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
    Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
    Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
    Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.
    Lavotshkin S; Jalas JR; Torisu-Itakura H; Ozao-Choy J; Lee JH; Sim MS; Stojadinovic A; Wainberg Z; Bifulco CB; Fox BA; Bilchik AJ
    J Gastrointest Surg; 2015 Jun; 19(6):999-1006. PubMed ID: 25808375
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD8+ and foxp3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype.
    Angell HK; Gray N; Womack C; Pritchard DI; Wilkinson RW; Cumberbatch M
    Br J Cancer; 2013 Sep; 109(6):1618-24. PubMed ID: 23963148
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic impact of foxp3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.
    Yoon HH; Orrock JM; Foster NR; Sargent DJ; Smyrk TC; Sinicrope FA
    PLoS One; 2012; 7(8):e42274. PubMed ID: 22879926
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer.
    Kemp RA; Black MA; McCall J; Yoon HS; Phillips V; Anjomshoaa A; Reeve AE
    J Exp Clin Cancer Res; 2011 Aug; 30(1):78. PubMed ID: 21864372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
    Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
    J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Regulatory (foxp3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.
    Correale P; Rotundo MS; Del Vecchio MT; Remondo C; Migali C; Ginanneschi C; Tsang KY; Licchetta A; Mannucci S; Loiacono L; Tassone P; Francini G; Tagliaferri P
    J Immunother; 2010 May; 33(4):435-41. PubMed ID: 20386463
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    Zlobec I; Lugli A
    World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intraepithelial effector (CD3+)/regulatory (foxp3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
    Sinicrope FA; Rego RL; Ansell SM; Knutson KL; Foster NR; Sargent DJ
    Gastroenterology; 2009 Oct; 137(4):1270-9. PubMed ID: 19577568
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.